LimX Dynamics (逐际动力), a Shenzhen-based embodied-AI robotics company, has reportedly submitted a confidential application for a Hong Kong initial public offering and is considering a fundraising of up to US$300 million, according to a Caixin report published on Aug. 20.
Because the application was reportedly made through Hong Kong’s confidential-filing route, LimX has not published a prospectus. The proposed fundraising amount, timetable, financial results and final listing terms therefore remain unconfirmed by the company or the exchange.
The reported filing follows a near-US$200 million Pre-IPO financing round completed in July at a post-money valuation of RMB15 billion (about US$2.1 billion). LimX said it had raised a total of US$400 million over the preceding six months. Investors in the Pre-IPO round included IDG Capital and Lens Technology, while existing shareholders including NIO Capital also participated.
The company said the new capital would support the integration of high-level cognition with whole-body control, deployment of thousands of fully autonomous humanoid robots, and expansion of its manufacturing, delivery and market presence in the Middle East, Europe and other Asian markets.
LimX’s international order mix is a notable part of its commercialization pitch. The company says it has secured thousands of customer orders across its product lines, with more than half coming from global markets. It has not publicly broken out the value, contractual status, delivery schedule or revenue recognition associated with those orders. The overseas share should therefore be read as a company-reported order metric, rather than evidence of recognized international sales.
Founded in Shenzhen in 2022, LimX has developed a portfolio that includes the full-size humanoid Oli, the full-size interactive humanoid Luna and the modular multi-form robot TRON 2. The company positions its technology around three pillars: robot hardware and manufacturing, whole-body motion control, and COSA, its embodied agentic operating system.
Luna began deliveries to customers in China and overseas less than a month after its May launch, according to LimX. The company also said TRON 2 has received orders from developers, research institutions and enterprise customers globally. Its target applications span research and education, commercial services, industrial work, inspection and construction.
A potential Hong Kong IPO would give LimX access to additional capital as it moves from product launches and early deliveries toward larger-scale manufacturing. But the principal test is still execution: converting its reported order pipeline into repeatable delivery, customer use and sustainable revenue while bringing down system and operating costs.
The company’s proposed listing also reflects the broader rush among Chinese embodied-AI companies to secure financing before commercial economics are fully proven. For overseas customers and investors, LimX’s progress will be measured less by demonstrations or order counts than by whether its robots can operate reliably in defined, paid-use scenarios at scale.